Yahoo
NSE - Delayed Quote INR

Piramal Pharma Limited (PPLPHARMA.NS)

237.77 +6.99 (+3.03%)
At close: October 30 at 3:29:59 PM GMT+5:30
Chart Range Bar
Loading chart for PPLPHARMA.NS
  • Previous Close 230.78
  • Open 229.95
  • Bid --
  • Ask 238.91 x --
  • Day's Range 225.82 - 240.00
  • 52 Week Range 132.30 - 240.00
  • Volume 26,855,814
  • Avg. Volume 6,445,192
  • Market Cap (intraday) 315.303B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) --
  • EPS (TTM) -1.58
  • Earnings Date (est.) Jan 27, 2027
  • Forward Dividend & Yield 0.14 (0.00%)
  • Ex-Dividend Date Jul 16, 2025
  • 1y Target Est 260.09

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids' wellness, digestives, and women's health, as well as geriatric care. In addition, the company operates as a contract development and manufacturing organization, providing process development, scale-up, and GMP manufacturing services for vaccines and biologics. The company was incorporated in 2020 and is based in Mumbai, India.

www.piramalpharma.com

7,120

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

PPLPHARMA.NS
38.07%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

PPLPHARMA.NS
17.77%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

PPLPHARMA.NS
149.45%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

PPLPHARMA.NS
21.74%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 26.17B
Earnings 55.8M
Profit Margin 0.21%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
10B
20B
-6.0%
-4.0%
-2.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

220.00 Low
260.09 Average
237.77 Current
300.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.14%

  • Return on Assets (ttm)

    1.14%

  • Return on Equity (ttm)

    -2.58%

  • Revenue (ttm)

    97.79B

  • Net Income Avi to Common (ttm)

    -2.09B

  • Diluted EPS (ttm)

    -1.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.3B

  • Total Debt/Equity (mrq)

    71.93%

  • Levered Free Cash Flow (ttm)

    -4.45B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: